About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us
More Company News
Redx Pharma
Interim H123 results for the six months ended 31 March
17 May 2023
Read More
Redx Pharma
RXC007 preclinical data
11 May 2023
Read More
Redx Pharma
Presentation at Keystone Symposia
03 May 2023
Read More
Redx Pharma
Proposed business combination formally lapsed
03 Apr 2023
Read More
Redx Pharma
Statement following Jounce announcement
27 Mar 2023
Read More
Redx Pharma
Statement re: Jounce Therapeutics press release
15 Mar 2023
Read More
Redx Pharma
RXC004 topline data from a Phase II monotherapy module
08 Mar 2023
Read More
Redx Pharma
Recommended business combination with Jounce Therapeutics
23 Feb 2023
Read More
Redx Pharma
Progress update on RXC007 clinical programme
09 Feb 2023
Read More
Redx Pharma
FY22 Results
20 Dec 2022
Read More
1
2
3
4
…
6
Return to Redx Pharma
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us